Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Pawlyn

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Blood|July 3, 2025
Check the brakes on IRF4!Charlotte Pawlyn
The Lancet. Haematology|December 28, 2020
High-risk myeloma: a challenge to define and to determine the optimal treatmentCharlotte Pawlyn
Nature|August 19, 2025
Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myelomaSarah Bird, Charlotte Pawlyn
Blood|March 17, 2023
IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impactSarah Bird, Charlotte Pawlyn
The Lancet. Haematology|December 2, 2022
Lenalidomide and risk of second primary malignancy-is disease context key?Charlotte Pawlyn, Sarah Bird
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
Predicting the Future: Machine-Based Learning for MRD PrognosticationCharlotte Pawlyn, Faith E Davies
Blood|December 28, 2018
Toward personalized treatment in multiple myeloma based on molecular characteristicsCharlotte Pawlyn, Faith E Davies
Nature Reviews. Cancer|August 25, 2017
Evolutionary biology of high-risk multiple myelomaCharlotte Pawlyn, Gareth J Morgan
British Journal of Hospital Medicine (London, England : 2005)|February 13, 2019
Physicians, paraproteins and progress: diagnosis and management of myelomaCharlotte Pawlyn, Graham H Jackson
Hematology. American Society of Hematology. Education Program|December 9, 2022
Fitness and frailty in myelomaCharlotte Pawlyn, Abdullah M Khan, Ciara L Freeman
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Blood|July 3, 2025
Check the brakes on IRF4!Charlotte Pawlyn
The Lancet. Haematology|December 28, 2020
High-risk myeloma: a challenge to define and to determine the optimal treatmentCharlotte Pawlyn
Nature|August 19, 2025
Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myelomaSarah Bird, Charlotte Pawlyn
Blood|March 17, 2023
IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impactSarah Bird, Charlotte Pawlyn
The Lancet. Haematology|December 2, 2022
Lenalidomide and risk of second primary malignancy-is disease context key?Charlotte Pawlyn, Sarah Bird
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
Predicting the Future: Machine-Based Learning for MRD PrognosticationCharlotte Pawlyn, Faith E Davies
Blood|December 28, 2018
Toward personalized treatment in multiple myeloma based on molecular characteristicsCharlotte Pawlyn, Faith E Davies
Nature Reviews. Cancer|August 25, 2017
Evolutionary biology of high-risk multiple myelomaCharlotte Pawlyn, Gareth J Morgan
British Journal of Hospital Medicine (London, England : 2005)|February 13, 2019
Physicians, paraproteins and progress: diagnosis and management of myelomaCharlotte Pawlyn, Graham H Jackson
Hematology. American Society of Hematology. Education Program|December 9, 2022
Fitness and frailty in myelomaCharlotte Pawlyn, Abdullah M Khan, Ciara L Freeman
Pageof 10